Yahoo Web Search

Search results

    • AbbVie Completes Acquisition of Landos Biopharma

      The Longview News-Journal· 2 days ago

      With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...

    • AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald

      ETF DAILY NEWS· 7 days ago

      Cantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald ...